Healthcare provider profile · identity verified

Jonathan D. Ruby, M.D.

Family Practice · SOMERSET, KY · NPI 1346395837

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	110
Levothyroxine Sodium	Levothyroxine Sodium	334	67
Omeprazole	Omeprazole	320	85
Gabapentin	Gabapentin	307	64
Lisinopril	Lisinopril	262	63
Metoprolol Tartrate	Metoprolol Tartrate	229	55
Furosemide	Furosemide	224	54
Amlodipine Besylate	Amlodipine Besylate	222	59
Trazodone Hcl	Trazodone Hcl	196	34
Sertraline Hcl	Sertraline Hcl	194	34
Mirtazapine	Mirtazapine	192	31
Buspirone Hcl	Buspirone Hcl	190	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	172	45
Rosuvastatin Calcium	Rosuvastatin Calcium	168	44
Clopidogrel	Clopidogrel Bisulfate	156	46
Duloxetine Hcl	Duloxetine Hcl	152	31
Pantoprazole Sodium	Pantoprazole Sodium	150	45
Famotidine	Famotidine	140	34
Eliquis	Apixaban	131	50
Oxycodone Hcl	Oxycodone Hcl	131	37
Metoprolol Succinate	Metoprolol Succinate	125	48
Potassium Chloride	Potassium Chloride	125	37
Metformin Hcl	Metformin Hcl	124	30
Losartan Potassium	Losartan Potassium	122	32
Ibuprofen	Ibuprofen	119	21
Tramadol Hcl	Tramadol Hcl	118	36
Donepezil Hcl	Donepezil Hcl	115	20
Citalopram Hbr	Citalopram Hydrobromide	107	19
Ondansetron Hcl	Ondansetron Hcl	105	34
Carvedilol	Carvedilol	100	32
Tamsulosin Hcl	Tamsulosin Hcl	94	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	87	17
Memantine Hcl	Memantine Hcl	86	14
Alprazolam	Alprazolam	82	21
Baclofen	Baclofen	81	suppressed
Clonazepam	Clonazepam	79	17
Methocarbamol	Methocarbamol	76	21
Diclofenac Sodium	Diclofenac Sodium	72	28
Loperamide	Loperamide Hcl	72	17
Quetiapine Fumarate	Quetiapine Fumarate	72	22
Xarelto	Rivaroxaban	65	19
Finasteride	Finasteride	64	11
Simvastatin	Simvastatin	64	12
Hydrochlorothiazide	Hydrochlorothiazide	62	19
Meloxicam	Meloxicam	60	14
Nifedipine Er	Nifedipine	60	13
Lorazepam	Lorazepam	59	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	50	14
Montelukast Sodium	Montelukast Sodium	50	15
Oxybutynin Chloride	Oxybutynin Chloride	50	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	suppressed
Celecoxib	Celecoxib	44	12
Fluoxetine Hcl	Fluoxetine Hcl	43	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Ozempic	Semaglutide	42	suppressed
Aripiprazole	Aripiprazole	41	suppressed
Jardiance	Empagliflozin	41	11
Diazepam	Diazepam	40	suppressed
Ondansetron Odt	Ondansetron	40	33
Dicyclomine Hcl	Dicyclomine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	17
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	14
Novolog	Insulin Aspart	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	26
Torsemide	Torsemide	34	suppressed
Prednisone	Prednisone	33	24
Veltassa	Patiromer Calcium Sorbitex	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	24
Promethazine Hcl	Promethazine Hcl	32	suppressed
Sotalol	Sotalol Hcl	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	21
Ezetimibe	Ezetimibe	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	12
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	13
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Entresto	Sacubitril/Valsartan	28	12
Lamotrigine	Lamotrigine	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Levetiracetam	Levetiracetam	27	13
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Cephalexin	Cephalexin	26	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Enoxaparin Sodium	Enoxaparin Sodium	23	11
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Ranolazine Er	Ranolazine	23	suppressed
Amantadine	Amantadine Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Dexamethasone	Dexamethasone	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Bethanechol Chloride	Bethanechol Chloride	20	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Nystatin	Nystatin	20	19
Spironolactone	Spironolactone	20	13
Atenolol	Atenolol	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	12
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Ssd	Silver Sulfadiazine	15	suppressed
Temazepam	Temazepam	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Digoxin	Digoxin	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nyamyc	Nystatin	14	suppressed
Primidone	Primidone	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Enulose	Lactulose	13	suppressed
Linzess	Linaclotide	13	suppressed
Mresvia	Rsv Vaccine, Pref, Mrna/Pf	13	13
Xifaxan	Rifaximin	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Glipizide	Glipizide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Testosterone	Testosterone	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Lactulose	Lactulose	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error